Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Figure 1 | Arthritis Research & Therapy

Figure 1

From: Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity

Figure 1

Plasma levels of soluble Mer are increased in discrete subsets of systemic lupus erythematosus patients. Levels of soluble Mer (sMer) or soluble Axl (sAxl) of 45 patients (pts) and 45 healthy controls (ctrls) were measured and compared by considering the whole groups (A) or by dividing patients and matched controls into subgroups according to disease activity (A), organ involvement (B) and autoantibody specificities (C, D and E). αCL, anticardiolipin immunoglobulin G; αDNA, anti-double-stranded DNA; αRo60, anti-Sjögren’s syndrome antigen A/Ro 60 KDa; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index.

Back to article page